Alterations in cell maturity and serum survival factors may modulate neutrophil numbers in sickle cell disease

Experimental Biology and Medicine

Volumn 236, Issue 11, 2011, Pages 1239-1246

  Almeida, Camila Bononi ^a   Favero, Maria Emilia ^a   Pereira Cunha, Fernanda Gonçalves ^a   Lorand Metze, Irene ^a   Saad, Sara T Olalla ^a   Costa, Fernando Ferreira ^a   Conran, Nicola ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Apoptosis; Cytokine; Inflammation; Neutrophil; Sickle cell disease

Indexed keywords

CASPASE 9; HYDROXYUREA; INTERLEUKIN 8;

ADULT; APOPTOSIS; ARTICLE; CELL MATURATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKOCYTE MIGRATION; MALE; NEUTROPHIL; SERUM; SICKLE CELL ANEMIA;

ADULT; AGED; ANEMIA, SICKLE CELL; APOPTOSIS; CASPASE 9; CELL ADHESION; CELL AGING; CELL CULTURE TECHNIQUES; CELL SURVIVAL; FEMALE; HUMANS; INTERLEUKIN-8; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; SERUM;

EID: 80055120959     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.011130     Document Type: Article

References (31)

1. Steinberg MH. Management of sickle cell disease. N Engl J Med 1999;340:21-30
2. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet 2004;364:1343-60
3. Turhan A, Weiss LA, Mohandas N, Coller BS, Frenette PS. Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proc Natl Acad Sci USA 2002;99:3047-51
4. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-44
5. Conran N, Saad ST, Costa FF, Ikuta T. Leukocyte numbers correlate with plasma levels of granulocyte-macrophage colony-stimulating factor in sickle cell disease. Ann Hematol 2007;86:255-61
6. Opdenakker G, Fibbe WE, Van Damme J. The molecular basis of leukocytosis. Immunol Today 1998;19:182-9
7. Djaldetti M, Bergman M, Salman H, Cohen AM, Fibach E, Bessler H. On the mechanism of post-splenectomy leukocytosis in mice. Eur J Clin Invest 2003;33:811-7
8. Walker A, Ward C, Taylor EL, Dransfield I, Hart SP, Haslett C, Rossi AG. Regulation of neutrophil apoptosis and removal of apoptotic cells. Curr Drug Targets Inflamm Allergy 2005;4:447-54
9. Conran N, Almeida CB, Lanaro C, Ferreira RP, Traina F, Saad ST, Costa FF. Inhibition of caspase-dependent spontaneous apoptosis via a cAMP-protein kinase A dependent pathway in neutrophils from sickle cell disease patients. Br J Haematol 2007;139:148-58
10. Hitomi J, Christofferson DE, Ng A, Yao J, Degterev A, Xavier RJ, Yuan J. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008;135:1311-23
11. Challa S, Chan FK. Going up in flames: necrotic cell injury and inflammatory diseases. Cell Mol Life Sci 2010;67:3241-53
12. Lanaro C, Franco-Penteado CF, Albuqueque DM, Saad ST, Conran N, Costa FF. Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy. J Leukoc Biol 2009;85:235-42
13. Scapini P, Lapinet-Vera JA, Gasperini S, Calzetti F, Bazzoni F, Cassatella MA. The neutrophil as a cellular source of chemokines. Immunol Rev 2000;177:195-203
14. English D, Andersen BR. Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque. J Immunol Methods 1974;5:249-52
15. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54
16. Almeida CB, Traina F, Lanaro C, Canalli AA, Saad ST, Costa FF, Conran N. High expression of the cGMP-specific phosphodiesterase, PDE9A, in sickle cell disease (SCD) and the effects of its inhibition in erythroid cells and SCD neutrophils. Br J Haematol 2008;142:836-44
17. Miguel LI, Almeida CB, Traina F, Canalli AA, Dominical VM, Saad STO, Costa FF, Conran N. Inhibition of phosphodiesterase 9A (PDE9A) reduces cytokine-stimulated in vitro adhesion of neutrophils from sickle cell anemia individuals. Inflamm Res 2011;60:633-42
18. Segel GB, Halterman MW, Lichtman MA. The paradox of the neutrophil's role in tissue injury. J Leukoc Biol 2011;89:359-72
19. Abboud M, Laver J, Blau CA. Granulocytosis causing sickle-cell crisis. Lancet 1998;351:959
20. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998;91:288-94
21. Goncalves MS, Queiroz IL, Cardoso SA, Zanetti A, Strapazoni AC, Adorno E, Albuquerque A, Sant'Ana A, dos Reis MG, Barral A, Barral Netto M. Interleukin 8 as a vaso-occlusive marker in Brazilian patients with sickle cell disease. Braz J Med Biol Res 2001;34:1309-13
22. Laterveer L, Lindley IJ, Heemskerk DP, Camps JA, Pauwels EK, Willemze R, Fibbe WE. Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8. Blood 1996;87:781-8
23. Kennedy AD, Deleo FR. Neutrophil apoptosis and the resolution of infection. Immunol Res 2009;43:25-61
24. Luo HR, Loison F. Constitutive neutrophil apoptosis: mechanisms and regulation. Am J Hematol 2008;83:288-95
25. Almeida CB, Franco-Penteado C, Saad ST, Costa FF, Conran N. Sickle cell disease serum induces NADPH enzyme subunit expression and oxidant production in leukocytes. Hematology 2010;15:422-9
26. Hallett JM, Leitch AE, Riley NA, Duffin R, Haslett C, Rossi AG. Novel pharmacological strategies for driving inflammatory cell apoptosis and enhancing the resolution of inflammation. Trends Pharmacol Sci 2008;29:250-7
27. Taylor SC, Shacks SJ, Mitchell RA, Banks A. Serum interleukin-6 levels in the steady state of sickle cell disease. J Interferon Cytokine Res 1995;15:1061-4
28. Hofman P. Molecular regulation of neutrophil apoptosis and potential targets for therapeutic strategy against the inflammatory process. Curr Drug Targets Inflamm Allergy 2004;3:1-9
29. Wiedmann MW, Mossner J, Baerwald C, Pierer M. TNF alpha inhibition as treatment modality for certain rheumatologic and gastrointestinal diseases. Endocr Metab Immune Disord Drug Targets 2009;9:295-314
30. Ostergaard C, Yieng-Kow RV, Larsen CG, Mukaida N, Matsushima K, Benfield T, Frimodt-Moller N, Espersen F, Kharazmi A, Lundgren JD. Treatment with a monocolonal antibody to IL-8 attenuates the pleocytosis in experimental pneumococcal meningitis in rabbits when given intravenously, but not intracisternally. Clin Exp Immunol 2000;122:207-11
31. Zigler M, Villares GJ, Lev DC, Melnikova VO, Bar-Eli M. Tumor immunotherapy in melanoma: strategies for overcoming mechanisms of resistance and escape. Am J Clin Dermatol 2008;9:307-11